Fintel reports that on November 5, 2025, Wells Fargo maintained coverage of NeuroPace (NasdaqGM:NPCE) with a Overweight recommendation.
Analyst Price Forecast Suggests 32.53% Upside
As of October 30, 2025, the average one-year price target for NeuroPace is $17.19/share. The forecasts range from a low of $13.13 to a high of $21.00. The average price target represents an increase of 32.53% from its latest reported closing price of $12.97 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for NeuroPace is 73MM, a decrease of 23.57%. The projected annual non-GAAP EPS is -1.83.
What is the Fund Sentiment?
There are 204 funds or institutions reporting positions in NeuroPace. This is an increase of 14 owner(s) or 7.37% in the last quarter. Average portfolio weight of all funds dedicated to NPCE is 0.08%, an increase of 25.40%. Total shares owned by institutions decreased in the last three months by 5.45% to 24,018K shares. 
The put/call ratio of NPCE is 0.38, indicating a bullish outlook.
What are Other Shareholders Doing?
Orbimed Advisors holds 2,614K shares representing 7.90% ownership of the company. In its prior filing, the firm reported owning 3,406K shares , representing a decrease of 30.30%. The firm decreased its portfolio allocation in NPCE by 27.28% over the last quarter.
Soleus Capital Management holds 2,313K shares representing 6.99% ownership of the company. In its prior filing, the firm reported owning 2,608K shares , representing a decrease of 12.76%. The firm decreased its portfolio allocation in NPCE by 26.07% over the last quarter.
First Light Asset Management holds 1,380K shares representing 4.17% ownership of the company. In its prior filing, the firm reported owning 1,584K shares , representing a decrease of 14.75%. The firm decreased its portfolio allocation in NPCE by 10.32% over the last quarter.
Armistice Capital holds 1,152K shares representing 3.48% ownership of the company. In its prior filing, the firm reported owning 1,154K shares , representing a decrease of 0.11%. The firm increased its portfolio allocation in NPCE by 4.24% over the last quarter.
Driehaus Capital Management holds 1,005K shares representing 3.04% ownership of the company. In its prior filing, the firm reported owning 803K shares , representing an increase of 20.08%. The firm decreased its portfolio allocation in NPCE by 5.85% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
